Page 95 - AN-4-2
P. 95

Advanced Neurology                                                   PVT in Indonesian neurological patients



            considering comorbidity where applicable. Detailed   Data were collected by trained psychologists and
            diagnostic and more demographic characteristics of the   psychology graduates, who administered the PVTs
            participants are provided in Table 1. Only participants with   individually and face-to-face to all participants. Before
            no apparent external incentives (e.g., patients not involved   administering the PVTs, participants with ND, recruited
            in  medicolegal  proceedings)  and  without  a  history  of   from Alzheimer’s Indonesia, nursing homes, and the
            psychiatric disorders were included in the study.  halfway house, were screened using the Indonesian
                                                               version of the Mini-Mental State Examination (MMSE).
                                                                                                            36
              Data collection took place from 2022 to early 2023,
            with participants recruited through convenience    Only candidates with MMSE scores of 26 or below were
                                                               recruited. The MMSE score for the two ND participants
            sampling. Participants in the ND group were recruited   recruited from the Dr. Cipto Mangunkusumo Hospital was
            from Alzheimer’s Indonesia (a non-profit organization   obtained from the hospital. In addition to the ND group,
            focused on dementia care and support),  several nursing   the MMSE was administered to participants in the PS
                                            35
            homes in the Greater Jakarta area, and a halfway house for   group before the PVTs. The MMSE was administered to the
            elderly transgender people in Jakarta. In addition, a small   ND and PS groups only. The MMSE was administered first
            number of participants were recruited from Dr  Cipto   (to participants in the ND and PS groups), followed by the
            Mangunkusumo Hospital. We had not anticipated      DS, TMJPI, and NV-MSVT. All tests were administered in
            recruiting only two ND participants from the hospitals.   a single session for each participant, with a break provided
            Participants in the PS and mixed-etiology groups were   upon request. Participants were encouraged to complete
            outpatients from the Neurology Department of Dr. Cipto   the tests to the best of their ability. Participants received
            Mangunkusumo Hospital and Atma Jaya Hospital in    research compensation for their participation (e.g., food or
            Jakarta.                                           money, depending on the institutions’ requests). After data

            2.3. Procedure                                     collection, the test administrators scored the PVTs for each
                                                               participant.
            This study was conducted in accordance with the Helsinki
            Declaration. Ethical approval was granted by the Research   2.4. Statistical analysis
            Ethics Committee of Atma Jaya Catholic University of   The sample size was calculated using an online Sample Size
            Indonesia (No: 0032L/III/LPPM-PM.10.05/12/2021), the   Calculator (http://wnarifin.github.io), with an expected
            Ethics Committee of the Faculty of Medicine, University of   specificity of 0.90, a confidence level (1-α) of 0.95, and a
            Indonesia—Cipto Mangunkusumo Hospital (No: KET387a/  precision of 0.10. The prevalence of poor symptom validity
            UN2.F1/ETIK/PPM.00.02/2022), and Atma Jaya Hospital   was estimated at 0.16, based on a previous meta-analysis
                                                                                                            14
            (No: 133/DIR-e/II/2022). Informed consent was obtained   on the prevalence of PVT failure rates in clinical groups.
            from the caregivers of participants with ND (i.e., family   Participants who dropped out were expected to be replaced
            members or nursing home staff), while those in the PS and   (with no anticipated dropout). This calculation resulted
            mixed-etiology groups provided their own consent.  in a minimum required sample size of 42 participants

            Table 1. Demographic characteristics and MMSE scores of participants
            Parameter                     ND (n=49)        PS (n=42)        Mixed‑etiology (n=47)     P‑value
            Mean age (SD)                  69.4 (9.1)      57.0 (12.0)          48.2 (15.5)           <0.001 a
            Education (%)                                                                              0.26 b
             No/minimal education           8 (16.3)         3 (7.1)              2 (4.3)
             Elementary (6 years)          10 (20.4)        7 (16.7)             6 (12.8)
             Secondary (9 – 12 years)      24 (49.0)        27 (64.3)            25 (53.2)
             Tertiary (more than 12 years)  7 (14.3)        5 (11.9)             14 (29.8)
            Gender (%)                                                                                 0.26 b
             Male                          22 (44.9)        16 (38.1)            26 (55.3)
             Female                        27 (55.1)        26 (61.9)            21 (44.7)
            MMSE mean score (SD)           21.7 (3.2)       27.0 (2.6)              -                 <0.001 c
            Notes:  The statistic was analyzed using ANOVA;  The statistic was analyzed using the Chi-square test,  The statistic was analyzed using the
                                                                              c
                 a
                                            b
            Mann–Whitney U‑test.
            Abbreviations: MMSE: Mini-mental state examination; ND: Neurocognitive disorder due to possible neurodegenerative disease group; PS: Post-stroke
            group.
            Volume 4 Issue 2 (2025)                         89                               doi: 10.36922/an.5661
   90   91   92   93   94   95   96   97   98   99   100